SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021241
Filing Date
2022-11-02
Accepted
2022-11-02 16:11:59
Documents
70
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rcus-20220930.htm   iXBRL 10-Q 3207466
2 EX-10.3 rcus-ex10_3.htm EX-10.3 31978
3 EX-31.1 rcus-ex31_1.htm EX-31.1 19371
4 EX-31.2 rcus-ex31_2.htm EX-31.2 19420
5 EX-32.1 rcus-ex32_1.htm EX-32.1 11525
6 EX-32.2 rcus-ex32_2.htm EX-32.2 11551
  Complete submission text file 0000950170-22-021241.txt   10611466

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rcus-20220930_lab.xml EX-101.LAB 482885
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rcus-20220930_cal.xml EX-101.CAL 51156
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rcus-20220930_pre.xml EX-101.PRE 347683
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rcus-20220930.xsd EX-101.SCH 74359
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rcus-20220930_def.xml EX-101.DEF 208883
64 EXTRACTED XBRL INSTANCE DOCUMENT rcus-20220930_htm.xml XML 2040789
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38419 | Film No.: 221354188
SIC: 2834 Pharmaceutical Preparations